Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Response to Letter to the Editor From He et al: "Dasiglucagon in Children With Congenital Hyperinsulinism up to 1 Year of Age: Results From a Randomized Clinical Trial".
Journal: The Journal of clinical endocrinology and metabolism
Published: February 06, 2025
Dasiglucagon in Children With Congenital Hyperinsulinism Up to 1 Year of Age: Results From a Randomized Clinical Trial.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 13, 2024
Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 25, 2023
Correction to: Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families.
Journal: Orphanet journal of rare diseases
Published: May 18, 2022
Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model.
Journal: Journal of managed care & specialty pharmacy
Published: March 25, 2022
A Comparative Study of Dasiglucagon Ready-to-Use Autoinjector and Glucagon Emergency Kit During Rescue from Simulated Severe Hypoglycemia.
Journal: Diabetes technology & therapeutics
Published: November 23, 2021
Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families.
Journal: Orphanet journal of rare diseases
Published: September 13, 2021
RESULTS OF A 24-WEEK TRIAL OF TECHNOSPHERE INSULIN VERSUS INSULIN ASPART IN TYPE 2 DIABETES.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: January 20, 2021
Comprehensive Pulmonary Safety Review of Inhaled Technosphere® Insulin in Patients with Diabetes Mellitus.
Journal: Clinical drug investigation
Published: July 29, 2020
Hypoglycaemia is reduced with use of inhaled Technosphere® Insulin relative to insulin aspart in type 1 diabetes mellitus.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: December 04, 2019
A multinational observational study assessing insulin use: Understanding the determinants associated with progression of therapy.
Journal: Diabetes, obesity & metabolism
Published: September 17, 2018
Last Updated: 09/26/2026